ORGO - Organogenesis Holdings reports Q4 results introduces FY 2023 revenue guidance March, 01 2023 04:29 PM Organogenesis Holdings Inc. Organogenesis Holdings press release ( NASDAQ: ORGO ): Q4 GAAP EPS of $0.06. Revenue of $115.5M (-9.7% Y/Y). Sees FY 2023 net revenue between $450.0 million and $462.0 million. For further details see: Organogenesis Holdings reports Q4 results, introduces FY 2023 revenue guidance